$540 Profit
ABLong Stock
Entry comments: SLD POSITION : Mastocytose results w/ masitinib (expected in Q3) are too risky
Exit comments: SLD POSITION : Mastocytose results w/ masitinib (expected in Q3) are too risky
| Date | Price | |
|---|---|---|
| Entry | 1/6/2015 | 12.65 |
| Exit | 7/8/2015 | 14.00 |
- Total Views211
- Position Size400
- Percentage10.67%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
